When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Bristol-Myers Squibb (NYSE:BMY) and Acceleron Pharma (NASDAQ:XLRN) announce that the New England Journal of Medicine has published results from BELIEVE, the Phase 3 study evaluating the safety and efficacy of Reblozyl (luspatercept-aamt) for the treatment of anemia in adults with beta thalassemia who require regular red blood cell (RBC) transfusions.
More news on: Bristol-Myers Squibb Company, Acceleron Pharma Inc., Healthcare stocks news,